Acknowledgment: The authors thank Sue S. Bornstein, MD, and Jacqueline W. Fincher, MD, for their contributions as the chairs of ACP's Health and Public Policy Committee and Medical Practice and Quality Committee, respectively, when the Board of Regents in July 2018 asked the committees to develop a new vision for the future of health care policy. They provided initial direction and guidance that led to the vision statements and policies that are in this call to action and the accompanying position papers.
Financial Support: Financial support for the development of this position paper came exclusively from the ACP operating budget.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose.
Corresponding Author: Robert Doherty, BA, American College of Physicians, 25 Massachusetts Avenue NW, Suite 700, Washington, DC 20001; e-mail,
[email protected].
Current Author Addresses: Mr. Doherty: American College of Physicians, 25 Massachusetts Avenue NW, Suite 700, Washington, DC 20001.
Dr. Cooney: Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239.
Dr. Mire: Heritage Medical Associates, 4230 Harding Pike, Suite 601 East, Nashville, TN 37205.
Dr. Engel: Louisiana State University Health Sciences Center, 1542 Tulane Avenue, New Orleans, LA 70112.
Dr. Goldman: 3001 Coral Hills Drive, Suite #340, Coral Springs, FL 33065.
Author Contributions: Conception and design: R. Doherty.
Analysis and interpretation of the data: R. Doherty, T.G. Cooney, R.D. Mire, L.S. Engel, J.M. Goldman.
Drafting of the article: R. Doherty, R.D. Mire, L.S. Engel, J.M. Goldman.
Critical revision for important intellectual content: R. Doherty, T.G. Cooney, R.D. Mire, L.S. Engel, J.M. Goldman.
Final approval of the article: R. Doherty, T.G. Cooney, R.D. Mire, L.S. Engel, J.M. Goldman.
Administrative, technical, or logistic support: R. Doherty.
Collection and assembly of data: R. Doherty.
This article is part of the Annals supplement “Better Is Possible: The American College of Physicians' Vision for the U.S. Health Care System.” The American College of Physicians was the sole funder for this supplement.
* Individuals who served on the Health and Public Policy Committee at the time of the article's approval were Thomas G. Cooney, MD (Chair); Lee S. Engel, MD (Vice Chair); George Abraham, MD; Tracey L. Henry, MD; David R. Hilden, MD; Akshay Kapoor, MS; Joshua D. Lenchus, DO; Suja Mathew, MD; Bridget M. McCandless, MD; Matthew T. Nelson, MD; Molly Southworth, MD; Fatima Syed, MD; and Mary Anderson Wallace, MD. Individuals who served on the Medical Practice and Quality Committee at the time of the article's approval were Ryan D. Mire, MD (Chair); Jason M. Goldman, MD (Vice Chair); Rebecca Andrews, MD; Lyle Baker, MD; Peter Basch, MD; Tanvir Hussain, MD; Sandra A. Kemmerly, MD; M. Douglas Leahy, MD; Joshua Liao, MD, MSc; Marianne C. Parshley, MD; Steven Peskin, MD; Louis Snitkoff, MD; and Lawrence Ward, MD, MPH. Approved by the ACP Board of Regents on 2 November 2019.
Where do we go from here: Research for development of Public Policy
I will be starting a MPH this summer, where I hope to learn more about how all of this works. For now, I would greatly appreciate hearing from anyone who is a little further down the road!
Not Enough
Where maybe 80% of all hospital admits in the US are avoidable, when the average diagnostic journey has at least 2 flaws, where the therapeutic journey is fraught with wrong therapy, to much therapy, to little AND occurs with little to no patient preference elicitation, no wonder the bill is so high and of dubious value. As someone said, "Every process is perfectly designed to get the results it gets." (Arthur Jones). Incrementalism may, and only may, achieve some of the noted goals 4 generations from now, at best. And, a focus on payment, coverage, etc. component of the effort is important but requires a complete overhaul. The delivery system, in general, is antiquated. Why are activities you want to happen, read prevention, mixed with rare or uncommon events. And, mixed with chronic care that has so many of its own care requirements. No wonder excellence is elusive.
And specifically to my ACP colleagues, figure out how to deliver excellent care 99+% of the time.
Why not bring the care to the customer versus the customer to the care, especially for care that one wants all to have that should have, no more, no less.
The money will follow the improved/transformed value proposition. The goals proposed will not seem as elusive as they do now.
Clean our own house, make it impeccable and settle for nothing less.
Medical Liability Cost.
I agree with much of the ACP recommendations. There has always been a tremendous disparity between payments for doing versus payment for the much more important cognitive function of primary care and IM. But having practiced for over 40 years (Internal Medicine and Gastroenterology), the ouitrageous medical liability costs in this country must to be addressed to reduce unnecessary costs associated with the need to CYA from our reckless injury attorneys. Some states have been more effective than others but Washington has never been willing to look at this problem (witness the "affordable care act").
Elimination of waste
1. I strongly believe that the establishment of a trusting relationship with a patient, taking a history that includes the usual PMH and asocial, employment/professional/educational/psychiatric/psychological/relevant travel/military experience and, depending on what is gleaned from above, additional history. This cannot be accomplished in 15 minutes. A questionairre to be filled out by the patient can be helpful but is only a starting point.
2. The intrusion of a "Pharmacy Benefits Manager" (PBM), wastes physician, staff, pharmacist and even insurance company time. The PBM may cause harm to the patient by delaying access to necessary medication and have been known to endanger patients by recommending different medication. Example: Substitute HCTZ for an ARB in an elderly paient with glucose intolerance, weell controlled HTN and strong FH of DM.
Disclosures:
I have a strong interest in staying alive and require appropriate access to my physician and medications.